Results 121 to 130 of about 45,519 (269)
Roflumilast for Oral Ulcers in Behçet's Disease and Recurrent Aphthous Stomatitis
The Journal of Dermatology, EarlyView.ABSTRACT Oral aphthous ulcer in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS) is a cause of discomfort for many patients, especially in cases refractory to colchicine or azathioprine. Roflumilast, a phosphodiesterase‐4 (PDE4) inhibitor, may be effective for treating refractory oral ulcers (OUs) in BD and RAS, especially in regions where
Kyung Bae Chung +4 more
wiley +1 more source
THE RENAL EFFECTS OF URETHANE AND COLCHICINE IN ADULT RATS [PDF]
, 1951 S. E. Dicker
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
BMJ, 2003 We describe three histories of patients with gout who were treated with doses of colchicine as advised by the British National Formulary (BNF)–that is, 1 mg initially followed by 500 μg every 2-3 hours until relief of pain is obtained or vomiting or diarrhoea occurs or until a total dose of 6 mg has been reached; the course should not be repeated ...
George I. Varughese +2 more
openaire +3 more sources
Digestive Endoscopy, EarlyView.The establishment of novel severity criteria for intestinal Behçet's disease. ABSTRACT Objective This study aimed to establish a novel severity classification for intestinal Behçet's disease (BD) (SCIBD) and validate its criteria across multiple institutions.
Toshiro Fukui +20 more
wiley +1 more source
Effects of colchicine and related substances on cell division [PDF]
, 1936 Austin M. Brues, Aaron A. Cohen
openalex +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims Compared to people without diabetes, individuals with type 1 diabetes have a several‐fold increased risk of cardiovascular (CV) morbidity and mortality despite guideline‐recommended management of traditional risk factors; so‐called residual CV risk.
David S. Mathiesen +13 more
wiley +1 more source
THE MECHANISM OF ACTION OF COLCHICINE [PDF]
, 1967 Gary G. Borisy, E. W. Taylor
openalex +3 more sources
European Journal of Clinical Investigation, EarlyView.Despite universal healthcare in Switzerland, disparities in post‐acute coronary syndrome (ACS) care persist across educational levels. In a cohort of 6040 patients, those with the lowest education had more cardiovascular risk factors and were less likely to attend cardiac rehabilitation or receive cardiology follow‐up.
Maëlle Achard +14 more
wiley +1 more source
Clinicopathological Challenge: A Progressively Enlarging Hardened Skin Plaque
International Journal of Dermatology, EarlyView.ABSTRACT Stiff skin syndrome (SSS) is a rare connective tissue disease manifesting as a progressive, non‐inflammatory fibrosis that causes the skin and soft tissues to harden. It can result in restricted joint movement, particularly affecting the shoulder and pelvic girdle. A segmental variant with a better prognosis has been described.
Marian Fernández Martínez +3 more
wiley +1 more source